Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy

Purpose: To present our experience in the examination and treatment of patients with peripheral exudative hemorrhagic chorioretinopathy (PEHCR). Material and Methods: We retrospectively reviewed the medical records of patients who were finally clinically diagnosed with PEHCR in the 2022-2023 peri...

Full description

Saved in:
Bibliographic Details
Main Authors: I. O. Nasinnyk, G. V. Levytska, M. M. Umanets
Format: Article
Language:English
Published: Ukrainian Society of Ophthalmologists 2024-10-01
Series:Journal of Ophthalmology
Subjects:
Online Access:https://ua.ozhurnal.com/index.php/files/article/view/187
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846168776522858496
author I. O. Nasinnyk
G. V. Levytska
M. M. Umanets
author_facet I. O. Nasinnyk
G. V. Levytska
M. M. Umanets
author_sort I. O. Nasinnyk
collection DOAJ
description Purpose: To present our experience in the examination and treatment of patients with peripheral exudative hemorrhagic chorioretinopathy (PEHCR). Material and Methods: We retrospectively reviewed the medical records of patients who were finally clinically diagnosed with PEHCR in the 2022-2023 period. History was collected and patients underwent ophthalmological examination including visual acuity, slit-lamp biomicroscopy, color fundus photography, fluorescein angiography and ocular ultrasound. All patients were treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapy. One patient underwent vitreoretinal surgery. Results: PEHCR was diagnosed in 11 patients (13 eyes), including two patients diagnosed with bilateral lesions. Clinical signs identified included a dome-shaped hemorrhagic detachment of the peripheral retinal pigment epithelium (RPE) with massive exudations. One patient underwent vitreoretinal surgery for vitreoretinal hemorrhage. On B-scan ultrasonography, the PEHCR lesion commonly presented as a dome or plateau-shaped mass with hollow or solid acoustic quality. Ten patients were treated with intravitreal aflibercept. Conclusion: PEHCR is a chronic disease commonly associated with AMD. Detachment of the peripheral RPE is a major clinical manifestation of the disease, and may be complicated by sub-RPE hemorrhage in early disease. Anti-VEGF therapy is a major method of treatment whereas vitreoretinal surgery is indicated in complications accompanied by massive intravitreal hemorrhage or macula-threatening subretinal hemorrhage. Further investigation is needed to elucidate the etiology and pathogenesis of this entity and demonstrate the efficacy and safety of the aforementioned treatment modalities for PEHCR.
format Article
id doaj-art-4097b7538c1e4b4a82941c39ea380212
institution Kabale University
issn 2412-8740
language English
publishDate 2024-10-01
publisher Ukrainian Society of Ophthalmologists
record_format Article
series Journal of Ophthalmology
spelling doaj-art-4097b7538c1e4b4a82941c39ea3802122024-11-13T12:27:47ZengUkrainian Society of OphthalmologistsJournal of Ophthalmology2412-87402024-10-015101410.31288/oftalmolzh202451014Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathyI. O. Nasinnyk0https://orcid.org/0000-0002-1717-5777G. V. Levytska1M. M. Umanets2SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine"SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine"SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine"Purpose: To present our experience in the examination and treatment of patients with peripheral exudative hemorrhagic chorioretinopathy (PEHCR). Material and Methods: We retrospectively reviewed the medical records of patients who were finally clinically diagnosed with PEHCR in the 2022-2023 period. History was collected and patients underwent ophthalmological examination including visual acuity, slit-lamp biomicroscopy, color fundus photography, fluorescein angiography and ocular ultrasound. All patients were treated with intravitreal anti-vascular endothelial growth factor (VEGF) therapy. One patient underwent vitreoretinal surgery. Results: PEHCR was diagnosed in 11 patients (13 eyes), including two patients diagnosed with bilateral lesions. Clinical signs identified included a dome-shaped hemorrhagic detachment of the peripheral retinal pigment epithelium (RPE) with massive exudations. One patient underwent vitreoretinal surgery for vitreoretinal hemorrhage. On B-scan ultrasonography, the PEHCR lesion commonly presented as a dome or plateau-shaped mass with hollow or solid acoustic quality. Ten patients were treated with intravitreal aflibercept. Conclusion: PEHCR is a chronic disease commonly associated with AMD. Detachment of the peripheral RPE is a major clinical manifestation of the disease, and may be complicated by sub-RPE hemorrhage in early disease. Anti-VEGF therapy is a major method of treatment whereas vitreoretinal surgery is indicated in complications accompanied by massive intravitreal hemorrhage or macula-threatening subretinal hemorrhage. Further investigation is needed to elucidate the etiology and pathogenesis of this entity and demonstrate the efficacy and safety of the aforementioned treatment modalities for PEHCR.https://ua.ozhurnal.com/index.php/files/article/view/187peripheral exudative hemorrhagic chorioretinopathypolypoidal choroidal vasculopathyhemorrhagic detachment of the pigment epithelium
spellingShingle I. O. Nasinnyk
G. V. Levytska
M. M. Umanets
Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
Journal of Ophthalmology
peripheral exudative hemorrhagic chorioretinopathy
polypoidal choroidal vasculopathy
hemorrhagic detachment of the pigment epithelium
title Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
title_full Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
title_fullStr Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
title_full_unstemmed Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
title_short Our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
title_sort our experience in the diagnosis and treatment of peripheral exudative hemorrhagic chorioretinopathy
topic peripheral exudative hemorrhagic chorioretinopathy
polypoidal choroidal vasculopathy
hemorrhagic detachment of the pigment epithelium
url https://ua.ozhurnal.com/index.php/files/article/view/187
work_keys_str_mv AT ionasinnyk ourexperienceinthediagnosisandtreatmentofperipheralexudativehemorrhagicchorioretinopathy
AT gvlevytska ourexperienceinthediagnosisandtreatmentofperipheralexudativehemorrhagicchorioretinopathy
AT mmumanets ourexperienceinthediagnosisandtreatmentofperipheralexudativehemorrhagicchorioretinopathy